• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下咽鳞癌中 Oct4 和 Sox2 表达的预后意义。

Prognostic significance of Oct4 and Sox2 expression in hypopharyngeal squamous cell carcinoma.

机构信息

State Key Laboratory of Oncology in South China, Cancer Center of Sun Yat-Sen University, Guangzhou 510060, China.

出版信息

J Transl Med. 2010 Oct 12;8:94. doi: 10.1186/1479-5876-8-94.

DOI:10.1186/1479-5876-8-94
PMID:20937145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2958910/
Abstract

BACKGROUND

Oct4 and Sox2 are two major transcription factors related to the stem cell self-renewal and differentiation. The aim of this study was to examine the association between Oct4 and Sox2 expression levels with both the clinicopathological characteristics and prognoses of patients with hypopharyngeal squamous cell carcinoma.

METHOD

Tumor tissue samples from 85 patients with hypopharyngeal squamous cell carcinoma were collected, and the clinical follow-up data of these patients were recorded, and expression status of Oct4 and Sox2 were examined in these tissue samples by immunohistochemistry (IHC).

RESULTS

Oct4 expression was found to be an independent predictive factor for overall survival (p = 0.004) in patients with hypopharyngeal squamous cell carcinoma and was independently related to loco-regional control (p = 0.001). Although Sox2 expression status showed no significant association with overall survival (p = 0.166), disease-free survival (p = 0.680) or loco-regional control (p = 0.383), when using a subgroup analysis, the subgroup with both high Oct4 and Sox2 expression had the best prognosis (p = 0.000). Sox2 expression could be a potential prognostic predictor for patients with hypopharyngeal squamous cell carcinoma. Simultaneous analyses of Oct4 and Sox2 expression could be more effective in evaluating the prognoses of patients with hypopharyngeal squamous cell carcinoma.

CONCLUSION

Oct4 expression is an independent predictive factor for patients with hypopharyngeal squamous cell carcinoma, suggesting that Oct4 expression may be a useful indicator for predicting the prognosis of hypopharyngeal squamous cell carcinoma.

摘要

背景

Oct4 和 Sox2 是与干细胞自我更新和分化相关的两个主要转录因子。本研究旨在探讨 Oct4 和 Sox2 表达水平与下咽鳞状细胞癌患者的临床病理特征和预后之间的关系。

方法

收集 85 例下咽鳞状细胞癌患者的肿瘤组织样本,记录这些患者的临床随访资料,并通过免疫组织化学(IHC)检测这些组织样本中 Oct4 和 Sox2 的表达状态。

结果

Oct4 表达被发现是下咽鳞状细胞癌患者总生存的独立预测因子(p = 0.004),并且与局部区域控制独立相关(p = 0.001)。虽然 Sox2 表达状态与总生存(p = 0.166)、无病生存(p = 0.680)或局部区域控制(p = 0.383)均无显著相关性,但在亚组分析中,同时具有高 Oct4 和 Sox2 表达的亚组具有最佳的预后(p = 0.000)。Sox2 表达可能是下咽鳞状细胞癌患者的潜在预后预测因子。同时分析 Oct4 和 Sox2 表达可能更有效地评估下咽鳞状细胞癌患者的预后。

结论

Oct4 表达是下咽鳞状细胞癌患者的独立预测因子,表明 Oct4 表达可能是预测下咽鳞状细胞癌预后的有用指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3c9/2958910/fb7c633cc073/1479-5876-8-94-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3c9/2958910/d81103f078eb/1479-5876-8-94-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3c9/2958910/fb7c633cc073/1479-5876-8-94-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3c9/2958910/d81103f078eb/1479-5876-8-94-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3c9/2958910/fb7c633cc073/1479-5876-8-94-2.jpg

相似文献

1
Prognostic significance of Oct4 and Sox2 expression in hypopharyngeal squamous cell carcinoma.下咽鳞癌中 Oct4 和 Sox2 表达的预后意义。
J Transl Med. 2010 Oct 12;8:94. doi: 10.1186/1479-5876-8-94.
2
Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.OCT4、SOX2和NANOG表达与口腔鳞状细胞癌进展的相关性
J Oral Pathol Med. 2016 Feb;45(2):89-95. doi: 10.1111/jop.12335. Epub 2015 Jul 25.
3
[Expression of Oct4 and Sox2 and their clinical significance in tongue squamous cell carcinoma].Oct4和Sox2在舌鳞状细胞癌中的表达及其临床意义
Zhonghua Kou Qiang Yi Xue Za Zhi. 2017 Jan 9;52(1):27-33. doi: 10.3760/cma.j.issn.1002-0098.2017.01.006.
4
Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non- Tumor Tissue.OCT4、SOX2和NANOG在口腔鳞状细胞癌与癌旁非肿瘤组织中的相对表达
Asian Pac J Cancer Prev. 2019 Jun 1;20(6):1649-1654. doi: 10.31557/APJCP.2019.20.6.1649.
5
Embryonic stem cell markers Sox-2 and OCT4 expression and their correlation with WNT signal pathway in cervical squamous cell carcinoma.胚胎干细胞标志物Sox-2和OCT4在宫颈鳞状细胞癌中的表达及其与WNT信号通路的相关性
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2470-6. eCollection 2014.
6
High Expression of SOX2 and OCT4 Indicates Radiation Resistance and an Independent Negative Prognosis in Cervical Squamous Cell Carcinoma.SOX2和OCT4的高表达表明宫颈鳞状细胞癌具有放射抗性及独立的不良预后。
J Histochem Cytochem. 2014 Jul;62(7):499-509. doi: 10.1369/0022155414532654. Epub 2014 Apr 7.
7
SOX2 expression in hypopharyngeal, laryngeal, and sinonasal squamous cell carcinoma.SOX2 在下咽、喉和鼻腔鼻窦鳞状细胞癌中的表达。
Hum Pathol. 2014 Apr;45(4):851-7. doi: 10.1016/j.humpath.2013.12.004. Epub 2013 Dec 21.
8
Cancer stem cell biomarkers SOX2 and Oct4 in cervical cancer patients undergoing chemoradiotherapy.宫颈癌患者接受放化疗后,癌症干细胞标志物 SOX2 和 Oct4。
Asia Pac J Clin Oncol. 2024 Jun;20(3):407-415. doi: 10.1111/ajco.14049. Epub 2024 Feb 25.
9
Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis.醛脱氢酶1(ALDH1)、CD44、八聚体结合转录因子4(OCT4)和性别决定区Y框蛋白2(SOX2)在舌鳞状细胞癌中的相关性及其与疾病进展和预后的关系
J Oral Pathol Med. 2014 Aug;43(7):492-8. doi: 10.1111/jop.12159. Epub 2014 Jan 23.
10
Epigenetic down-regulation of SOX2 is an independent poor prognostic factor for hypopharyngeal cancers.SOX2 的表观遗传下调是下咽癌的一个独立的不良预后因素。
Histopathology. 2018 Apr;72(5):826-837. doi: 10.1111/his.13436. Epub 2018 Jan 23.

引用本文的文献

1
OCT4 and MENA immunoprofiling in salivary mucoepidermoid carcinoma.唾液腺黏液表皮样癌中OCT4和MENA的免疫分析
Diagn Pathol. 2025 May 27;20(1):67. doi: 10.1186/s13000-025-01665-8.
2
The role of OCT4 and CD44 in lower lip carcinogenesis.OCT4和CD44在下唇癌发生中的作用。
Oral Maxillofac Surg. 2025 Jan 17;29(1):36. doi: 10.1007/s10006-024-01324-0.
3
Surrogate Immunohistochemical Markers of Proliferation and Embryonic Stem Cells in Distinguishing Ameloblastoma from Ameloblastic Carcinoma.在鉴别造釉细胞瘤和造釉细胞癌时,增殖和胚胎干细胞的替代免疫组织化学标志物。

本文引用的文献

1
SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity.胶质母细胞瘤肿瘤起始细胞中SOX2基因沉默会导致增殖停止和致瘤性丧失。
Stem Cells. 2009 Jan;27(1):40-8. doi: 10.1634/stemcells.2008-0493.
2
(-)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells.(-)-表没食子儿茶素-3-没食子酸酯(EGCG)抑制人肝细胞生长因子诱导的下咽癌细胞侵袭和转移。
Cancer Lett. 2008 Nov 18;271(1):140-52. doi: 10.1016/j.canlet.2008.05.048. Epub 2008 Jul 15.
3
Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.
Head Neck Pathol. 2024 Oct 4;18(1):92. doi: 10.1007/s12105-024-01704-8.
4
Expression of Pluripotency Factors OCT4 and LIN28 Correlates with Survival Outcome in Lung Adenocarcinoma.多能性因子 OCT4 和 LIN28 的表达与肺腺癌的生存结局相关。
Medicina (Kaunas). 2024 May 26;60(6):870. doi: 10.3390/medicina60060870.
5
Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma.头颈部鳞状细胞癌中的癌症干细胞
J Pharm Bioallied Sci. 2023 Jul;15(Suppl 2):S826-S830. doi: 10.4103/jpbs.jpbs_81_23. Epub 2023 Jul 11.
6
The Antiproliferative Activity of Extract and/or Piceatannol in Phenylhydrazine-Induced Colon Cancer in Male Albino Rats: The miR-145 Expression of the // and // Pathways.姜黄提取物和/或白皮素在苯肼诱导的雄性白化病大鼠结肠癌中的抗增殖活性://和//通路的 miR-145 表达。
Molecules. 2023 Jul 20;28(14):5543. doi: 10.3390/molecules28145543.
7
LncRNA LINC01569 promotes M2 macrophage polarization to accelerate hypopharyngeal carcinoma progression through the miR-193a-5p/FADS1 signaling axis.长链非编码RNA LINC01569通过miR-193a-5p/FADS1信号轴促进M2巨噬细胞极化,加速下咽癌进展。
J Cancer. 2023 Jun 4;14(9):1673-1688. doi: 10.7150/jca.83466. eCollection 2023.
8
Prognostic and predictive roles of cancer stem cell markers in head and neck squamous cell carcinoma patients receiving chemoradiotherapy with or without nimotuzumab.在接受放化疗联合或不联合尼妥珠单抗治疗的头颈部鳞状细胞癌患者中,肿瘤干细胞标志物的预后和预测作用。
Br J Cancer. 2022 Jun;126(10):1439-1449. doi: 10.1038/s41416-022-01730-9. Epub 2022 Feb 9.
9
Prognostic value of octamer binding transcription factor 4 for patients with solid tumors: A meta-analysis.八聚体结合转录因子4对实体瘤患者的预后价值:一项荟萃分析。
Medicine (Baltimore). 2020 Oct 16;99(42):e22804. doi: 10.1097/MD.0000000000022804.
10
Diagnostic significance and carcinogenic mechanism of pan-cancer gene POU5F1 in liver hepatocellular carcinoma.POU5F1 基因在肝癌中的多癌种诊断意义及其致癌机制。
Cancer Med. 2020 Dec;9(23):8782-8800. doi: 10.1002/cam4.3486. Epub 2020 Sep 26.
口腔癌干细胞和高级别口腔鳞状细胞癌中Oct-4与Nanog的正相关性。
Clin Cancer Res. 2008 Jul 1;14(13):4085-95. doi: 10.1158/1078-0432.CCR-07-4404.
4
The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer.调控SOX2在乳腺癌中致癌潜能的分子机制。
J Biol Chem. 2008 Jun 27;283(26):17969-78. doi: 10.1074/jbc.M802917200. Epub 2008 May 2.
5
Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene.口咽和下咽鳞状细胞癌的总生存率和无复发生存率与GNAS1基因T393C多态性的基因型相关。
Clin Cancer Res. 2008 Mar 15;14(6):1753-8. doi: 10.1158/1078-0432.CCR-07-1605.
6
SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis.SOX2在胃癌中经常下调,并通过细胞周期阻滞和凋亡抑制细胞生长。
Br J Cancer. 2008 Feb 26;98(4):824-31. doi: 10.1038/sj.bjc.6604193. Epub 2008 Feb 12.
7
Impaired generation of mature neurons by neural stem cells from hypomorphic Sox2 mutants.来自低表达Sox2突变体的神经干细胞生成成熟神经元的能力受损。
Development. 2008 Feb;135(3):541-57. doi: 10.1242/dev.010801. Epub 2008 Jan 2.
8
Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells.在小鼠胚胎干细胞中,多能性由Sox2通过调控Oct3/4表达来控制。
Nat Cell Biol. 2007 Jun;9(6):625-35. doi: 10.1038/ncb1589. Epub 2007 May 21.
9
Cancer statistics, 2007.2007年癌症统计数据。
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66. doi: 10.3322/canjclin.57.1.43.
10
OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer.OCT-4是一种胚胎干细胞标志物,在膀胱癌中高表达。
Int J Cancer. 2007 Apr 1;120(7):1598-602. doi: 10.1002/ijc.22508.